ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 936,51
-1,38%
Dow Jones
41 420,47
-1,17%
DAX
22 298,83
-1,36%
Brent Oil
69,745
1,02%
Bitcoin
79 868,52
1,78%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Conduit Pharmaceuticals Inc (CDT)

  7. Conduit Pharmaceuticals Inc (CDT) Actualités

CDT

Conduit Pharmaceuticals (CDT)

Conduit Pharmaceuticals Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:CDT
DateHeureSourceTitreSymboleSociété
06/03/202515h35GlobeNewswire Inc.Conduit Pharmaceuticals Provides Update on Nasdaq Stock Market Hearing PanelNASDAQ:CDTConduit Pharmaceuticals Inc
20/02/202514h00GlobeNewswire Inc.Conduit Progresses Phase II of its AI Initiative with SarborgNASDAQ:CDTConduit Pharmaceuticals Inc
13/02/202514h00GlobeNewswire Inc.Conduit Pharmaceuticals Partners with Charles River in Clinically Relevant Systemic Lupus Erythematosus ModelNASDAQ:CDTConduit Pharmaceuticals Inc
11/02/202515h00GlobeNewswire Inc.Conduit Pharmaceuticals Announces Debt Repayment and Partial Conversion of Senior Secured NoteNASDAQ:CDTConduit Pharmaceuticals Inc
07/02/202514h00GlobeNewswire Inc.Conduit Pharmaceuticals Transitions to Phase II of Sarborg Collaboration to Support AI-Driven Drug DevelopmentNASDAQ:CDTConduit Pharmaceuticals Inc
28/01/202511h30GlobeNewswire Inc.Conduit Pharmaceuticals Completes Strategic Review with Sarborg to Map Revolutionizing Drug Development with Artificial IntelligenceNASDAQ:CDTConduit Pharmaceuticals Inc
23/01/202514h00GlobeNewswire Inc.Conduit Pharmaceuticals Inc. Announces Reverse Stock SplitNASDAQ:CDTConduit Pharmaceuticals Inc
22/01/202514h00GlobeNewswire Inc.Conduit Pharmaceuticals Partners with Agility Life Sciences to Create Enhanced Formulations for its Autoimmune PipelineNASDAQ:CDTConduit Pharmaceuticals Inc
12/12/202413h30GlobeNewswire Inc.Conduit Pharmaceuticals to Revolutionize Drug Development Through Agreement to Use Artificial Intelligence and CyberneticsNASDAQ:CDTConduit Pharmaceuticals Inc
21/11/202413h30GlobeNewswire Inc.Conduit Pharmaceuticals Receives Further Patent Approval For Lead Asset Targeting Autoimmune DisordersNASDAQ:CDTConduit Pharmaceuticals Inc
19/11/202422h30GlobeNewswire Inc.Conduit Pharmaceuticals Announces Appointment of Simon Fry to Board of DirectorsNASDAQ:CDTConduit Pharmaceuticals Inc
01/11/202421h45GlobeNewswire Inc.Conduit Pharmaceuticals Announces Debt Restructuring and Additional NotesNASDAQ:CDTConduit Pharmaceuticals Inc
28/08/202414h00GlobeNewswire Inc.Conduit Pharmaceuticals to Present at the H.C. Wainwright 26th Annual Global Investment ConferenceNASDAQ:CDTConduit Pharmaceuticals Inc
12/08/202413h00GlobeNewswire Inc.Conduit Pharmaceuticals Selects Initial Indications for Lead Clinical Candidate Targeting Autoimmune DisordersNASDAQ:CDTConduit Pharmaceuticals Inc
08/08/202412h30GlobeNewswire Inc.Conduit Pharmaceuticals Enters into Exclusive License Agreement with AstraZeneca for Multiple Assets to Advance Potential First-in-Class TreatmentsNASDAQ:CDTConduit Pharmaceuticals Inc
16/07/202413h30GlobeNewswire Inc.Conduit Pharmaceuticals Receives Patent Approval For Its Lead Asset Targeting Autoimmune DiseasesNASDAQ:CDTConduit Pharmaceuticals Inc
13/06/202414h00GlobeNewswire Inc.Conduit Pharmaceuticals to Join Russell 3000® IndexNASDAQ:CDTConduit Pharmaceuticals Inc
29/05/202422h21GlobeNewswire Inc.A Presidio Property Trust Major Investment To Be Part of Russell 2000®NASDAQ:CDTConduit Pharmaceuticals Inc
19/03/202412h00GlobeNewswire Inc.Conduit Pharmaceuticals Appoints Dr. Joanne Holland as Chief Scientific OfficerNASDAQ:CDTConduit Pharmaceuticals Inc
11/03/202412h00GlobeNewswire Inc.Conduit Pharmaceuticals Announces Opening of Prime Laboratory Space in Europe’s Leading Life Sciences HubNASDAQ:CDTConduit Pharmaceuticals Inc
31/01/202414h30GlobeNewswire Inc.Conduit Pharmaceuticals to Present at the Oppenheimer 34th Annual Healthcare Life Sciences ConferenceNASDAQ:CDTConduit Pharmaceuticals Inc
02/11/202313h30GlobeNewswire Inc.Conduit Pharmaceuticals to Participate in the 14th Annual Jefferies London Healthcare ConferenceNASDAQ:CDTConduit Pharmaceuticals Inc
11/10/202314h30GlobeNewswire Inc.Conduit Pharmaceuticals Partners with ClinConnect on Cocrystal Development Program for AZD1656NASDAQ:CDTConduit Pharmaceuticals Inc
06/10/202314h30GlobeNewswire Inc.Presidio Property Trust Announces Closing of Merger of Its Sponsored SPAC Murphy Canyon Acquisition Corp Now Trading as Conduit Pharmaceuticals (Nasdaq: CDT and CDTTW)NASDAQ:CDTConduit Pharmaceuticals Inc
22/09/202315h01GlobeNewswire Inc.Conduit Pharmaceuticals and Murphy Canyon Acquisition Corp. Announce Completion of Business CombinationNASDAQ:CDTConduit Pharmaceuticals Inc
10/11/200318h26PR Newswire (US)Mohawk/CDT Announces the Release of VersaLite(TM) Indoor/Outdoor Plenum Fiber Optic CableNYSE:CDT
 Showing the most relevant articles for your search:NASDAQ:CDT

Dernières Valeurs Consultées

BOV
HGRU11
Patria Renda Urbana Fund...
TG
M1ZD
Republic of Macedonia
BIT
SUNI5S
Societe Generale Effekten
LSE
TOU
Touch Group
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés

Supprimer les publicités

Inscrivez-vous pour une expérience sans publicité

Aucune publicité

Essayez maintenant

Conserver les annonces